Collagen powders are everywhere, but most come with vague promises and little human data. This one comes with a double-blind, placebo-controlled trial. In it, 2.5 grams a day of a specific bioactive collagen peptide cut eye wrinkle volume by 20% versus placebo after 8 weeks. Biopsies also showed higher procollagen type I in the skin. The catch is that the result belongs to one branded peptide, Verisol, tested in one group of women. It does not belong to every tub of collagen on the shelf.
This article covers what the study did, what it found, and how far the results stretch.
What the Study Did
The paper is Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. It was written by Proksch E, Schunck M, Zague V, Segger D, Degwert J and Oesser S, and published in Skin Pharmacology and Physiology in 2014 (27(3):113-9). The full record is on PubMed.
The design:
- 114 women aged 45-65, randomized 1:1 (57 per group)
- 2.5 g of the bioactive collagen peptide Verisol, or placebo, once daily for 8 weeks
- Double-blind and placebo-controlled
- Wrinkles measured objectively at baseline, 4 weeks and 8 weeks, plus a 4-week regression phase after the last dose
- A subgroup had suction blister biopsies at baseline and 8 weeks. These measured procollagen I, elastin and fibrillin in the skin.
The objective wrinkle measurements and the tissue-level biopsies are what set this trial apart from a typical supplement study built on self-reported "my skin feels better" surveys.
Bioactive Collagen Peptides vs. Generic Collagen
Collagen is a structural protein. "Collagen supplements" can mean very different things, from gelatin to loosely defined hydrolyzed powders. A bioactive collagen peptide (BCP) is a defined, specific peptide preparation. The point of the Verisol paper is that the researchers tested one particular BCP, not collagen in general.
The authors say so directly. Their conclusion concerns "specific bioactive collagen peptides (Verisol®)." If you buy a different collagen product, this trial tells you nothing about whether it would work. It might, but this study can't say.
Key Results, With the Exact Numbers
Wrinkles
- Eye wrinkle volume dropped significantly (p < 0.05) versus placebo at both 4 and 8 weeks. The reduction at 8 weeks was 20%.
- A positive, long-lasting effect was still significant (p < 0.05) 4 weeks after the last dose.
Skin matrix (biopsy subgroup, after 8 weeks vs. placebo)
- Procollagen type I: +65%
- Elastin: +18%
- Fibrillin: +6%, which did not reach statistical significance
The fibrillin result is easy to skip over in a headline. It was a nonsignificant trend, so it shouldn't be counted as a win.
The Proposed Mechanism
The paper's title ties the wrinkle effect to "increased dermal matrix synthesis." Procollagen I is the precursor of type I collagen, the main structural collagen in skin. Elastin gives skin its elasticity. Higher levels of both in the treated group fit with the visible wrinkle reduction.
Still, the abstract reports associations measured in the same trial. It doesn't show that the matrix changes caused the wrinkle reduction. It also doesn't establish exactly how the peptides signal skin cells. Treat the mechanism as plausible and supported by the biopsy data, not as fully mapped.
Limitations: Read This Before You Buy
The findings are encouraging, and the limits matter just as much:
- Women aged 45-65 only. Men and younger or older women weren't tested.
- 8 weeks of intake plus a 4-week follow-up. The trial says nothing about benefits or risks over a year or more.
- One branded peptide. The results don't transfer to other collagen products.
- One outcome focus: eye wrinkles. The abstract doesn't report on other facial areas or the body.
- Biopsies came from a subgroup, not all 114 participants.
- Fibrillin didn't reach significance.
- The abstract doesn't report adverse events, so it can't be used to make safety claims.
The authors also note that few clinical studies support the claim that food supplements improve skin aging. This trial adds data, but it is a single study, and independent replication would strengthen the case.
What It Means for You: Practical Takeaways
What was used
- Dose: 2.5 g of the bioactive collagen peptide Verisol
- Frequency: once daily
- Duration: 8 weeks. That is the period tested, and a significant effect was already visible at week 4.
- Timing: the paper specifies once daily. It doesn't test morning versus evening or with versus without food, so there's no evidence-based "best time."
Who it's most relevant to
- Women roughly 45-65 interested in fine lines around the eyes, which matches the studied population.
- Biohackers who want a supplement with objective, placebo-controlled skin data behind it.
Who should be cautious or skip it
- Anyone outside the studied group should treat the benefit as unproven, not ruled out.
- People with food allergies or dietary restrictions should check a product's collagen source and ingredient list. The abstract doesn't describe the source material.
- Pregnant or breastfeeding people, and anyone with a medical condition or on medication, should check with a clinician first. This trial doesn't address those groups.
- If your product isn't Verisol, don't assume the 20% figure applies to it.
Safety The abstract doesn't discuss side effects or tolerability, so there are no safety conclusions to draw from it. Don't read that as a guarantee either way.
Realistic expectations A 20% reduction in eye wrinkle volume versus placebo is a measurable, modest improvement. It isn't a facelift or a replacement for sunscreen. The effect also persisted for at least 4 weeks after stopping, which suggests the benefit isn't purely transient. The study doesn't show how long it lasts beyond that.
The Bottom Line
The trial is among the more convincing pieces of human data in the collagen category. 2.5 g a day of Verisol for 8 weeks cut eye wrinkle volume by 20% versus placebo, and skin biopsies showed 65% more procollagen type I and 18% more elastin. The evidence is narrow: women 45-65, a short duration, and one branded peptide. If you want to replicate it, look for that specific peptide at that specific dose. Otherwise, you're running your own experiment.
Source: Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol. 2014;27(3):113-9. doi: 10.1159/000355523. PubMed.
